Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
The change of sAA after stroop test in GAD patients can predict the severity of anxiety, but subjective psychological perception can not.
|
31726179 |
2020 |
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
We examined physiological stress responses (cortisol and salivary alpha-amylase [sAA]), negative emotional stress responses (anxiety and self-conscious emotions), and post-task ruminative thoughts.
|
30265076 |
2019 |
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
We examined physiological stress responses (cortisol and salivary alpha-amylase [sAA]), negative emotional stress responses (anxiety and self-conscious emotions), and post-task ruminative thoughts.
|
31497984 |
2019 |
Anxiety Disorders
|
0.050 |
AlteredExpression
|
group |
BEFREE |
The following outcomes will be recorded: completion of dental treatment, anxiety scores at baseline and after treatment using Frankl rating behavior scale and physiological anxiety related changes will be recorded using salivary Alpha Amylase and Cortisol levels.
|
31464945 |
2019 |
Anxiety Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
<b>Methods:</b> Salivary α-amylase (sAA), galvanic skin response (GSR) and anxiety were assessed over a 2-h operating flight.
|
29867525 |
2018 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
We identified a panel of three protein biomarkers, salivary alpha amylase (AMY1), Flt3 ligand (FLT3L), and monocyte chemotactic protein 1 (MCP1), which are upregulated in human patients receiving fractionated doses of total body irradiation (TBI) therapy as a treatment for cancer.
|
30605362 |
2020 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Emotion regulation and positive affect in the context of salivary alpha-amylase response to pain in children with cancer.
|
29350481 |
2018 |
Malignant Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
On the basis of these results, the clinical occurrence of amylase-producing cancer likely relates to the tissues expressing the AMY1 gene, while the AMY2B gene, which evolutionarily is the oldest gene among human amylase isogenes, is constitutively expressed in various tissues.
|
7507116 |
1994 |
Primary malignant neoplasm
|
0.030 |
AlteredExpression
|
group |
BEFREE |
On the basis of these results, the clinical occurrence of amylase-producing cancer likely relates to the tissues expressing the AMY1 gene, while the AMY2B gene, which evolutionarily is the oldest gene among human amylase isogenes, is constitutively expressed in various tissues.
|
7507116 |
1994 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
We identified a panel of three protein biomarkers, salivary alpha amylase (AMY1), Flt3 ligand (FLT3L), and monocyte chemotactic protein 1 (MCP1), which are upregulated in human patients receiving fractionated doses of total body irradiation (TBI) therapy as a treatment for cancer.
|
30605362 |
2020 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
Emotion regulation and positive affect in the context of salivary alpha-amylase response to pain in children with cancer.
|
29350481 |
2018 |
Adenocarcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
The possibility of HSGA should be considered when an adenocarcinoma producing human salivary alpha-amylase is diagnosed away from sites where major and minor salivary glands normally are found.
|
9258723 |
1997 |
Drug abuse
|
0.010 |
Biomarker
|
group |
BEFREE |
There was also a positive correlation between sAA reactivity and the CTQ subscales of childhood physical abuse (r = .46, p = .005) and emotional abuse (r = .37, p = .024).
|
27577885 |
2017 |
Hypertensive disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Areas under the receiver operator characteristic analysis revealed that the cutoff values of salivary alpha-amylase for identifying moderate-severe OSA and OSA concomitant hypertension were 17.64 U/mL (sensitivity 85%, specificity 91%) and 25.35 U/mL (sensitivity 70%, specificity 94%), respectively.
|
31126512 |
2019 |
Liver neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The results indicated that the parotid gland and hepatoma (also liver) clearly expressed AMY 1 and AMY 2B genes, respectively.
|
12104089 |
2002 |
Periodontal Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Batch injection analysis towards auxiliary diagnosis of periodontal diseases based on indirect amperometric detection of salivary α-amylase on a cupric oxide electrode.
|
30340690 |
2018 |
Pituitary Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Here, a study protocol is presented that allows the assessment of associations between music listening and psychobiological stress in daily life by noninvasively measuring salivary cortisol (as a marker of the Hypothalamic-Pituitary-Adrenal (HPA) axis) and salivary alpha-amylase (as a marker of the Autonomic Nervous System (ANS)).
|
28190047 |
2017 |
Temporomandibular Joint Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
No significant differences were observed in the salivary cortisol area under the curve (AUCG mean ± SD = 90.22 ± 63.36 × 94.21 ± 63.13 µg/dL/min) and sAA AUCG (mean ± SD = 2544.52 ± 2142.00 × 2054.03 ± 1046.89 U/mL/min) between the TMD and control groups, respectively (p > 0.05); however, the clinical groups differed in social anxiety domain (t = 3.759; CI = 2.609, 8.496), separation/panic (t = 2.243; CI = 0.309, 5.217), physical symptoms (U = 433.500), and MASC total score (t = -3.527; CI = -23.062, -6.412), with a power of the test >80% and large effect size (d = 0.80), with no significant correlation between the MASC total score, cortisol, and sAA levels.
|
29019550 |
2017 |
Caffeine related disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
In this follow-up article, the effects of strategic caffeine administration on the previously reported diurnal profiles of sAA and performance, and the association between sAA and neurobehavioural performance were investigated.
|
29402402 |
2019 |
Pervasive Development Disorder
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Not only do these results confirm the stress-reducing nature of two types of multisensory therapy, but they support the use of sAA as a potential tool for evaluating stress levels in individuals with intellectual disability and autism spectrum disorder, providing an important physiological lens that may guide strategies in clinical and non-clinical care for individuals with disabilities.
|
29159888 |
2018 |
Intellectual Disability
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Not only do these results confirm the stress-reducing nature of two types of multisensory therapy, but they support the use of sAA as a potential tool for evaluating stress levels in individuals with intellectual disability and autism spectrum disorder, providing an important physiological lens that may guide strategies in clinical and non-clinical care for individuals with disabilities.
|
29159888 |
2018 |
Depressed mood
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Child depression has been inconsistency linked to cortisol and salivary alpha-amylase (sAA) reactivity.
|
31707039 |
2020 |
Depressed mood
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Elevated salivary alpha-amylase levels at awakening in patients with depression.
|
30005283 |
2018 |
Emotional abuse
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
There was also a positive correlation between sAA reactivity and the CTQ subscales of childhood physical abuse (r = .46, p = .005) and emotional abuse (r = .37, p = .024).
|
27577885 |
2017 |
Emotional abuse
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
We tested whether EA moderated the relation between fractional anisotropy (FA), a measure of white matter fiber structure, and sAA.
|
29740273 |
2018 |